Outset Medical, Inc. provided revenue guidance for the full year 2023. for the year, the company expects revenue guidance range of $144 million to $150 million, and now expects to be at the low end of this range as a result of the shipment pause for TabloCart with Prefiltration.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.73 USD | +5.07% | -3.62% | -31.05% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.05% | 193M | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.29% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.6B |
- Stock Market
- Equities
- OM Stock
- News Outset Medical, Inc.
- Outset Medical, Inc. Provides Revenue Guidance for the Full Year 2023